A DIALOGUE BETWEEN REGULATORS AND THE PHARMA INDUSTRY ON MODERN GMP INSPECTION STANDARDS
On June 27, 2017 the Association of International Pharmaceutical Manufacturers (AIPM) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), supported by the State Institute of Medicines and Good Practices of the Russian Ministry of Industry and Trade (SIM & GxP), held a scientific and practical Workshop “Modern tendencies in GMP inspections of pharmaceutical manufacturers”. Representatives of regulatory authorities and expert organizations from Russia and Kazakhstan, representatives of headquarters and Russian branches of international pharmaceutical companies as well as recognized international experts participated in this discussion.
Russian Pharmaceutical Forum of Adam Smith Conferences
Russian Pharmaceutical Forum will be taking place in Saint Petersburg on May 16-17, 2017.
Russian Pharmaceutical Forum 2017 is the foremost gathering of CEOs of international and local pharmaceutical producers, distributors and retailers. From global strategies to specific operational topics, current situations and development predictions – an in-depth analysis of the situation in the pharma sector in Russia will be presented at the Forum.
The leading industry associations have signed a Memorandum of Understanding
December 29, 2016
On December 28, 2016 at the National Medical Chamber a Memorandum of Understanding was officially signed between the leading industry associations of Russia: The National Medical Chamber, represented by President Leonid Roshal; the National Pharmaceutical Chamber, represented by Executive Director Elena Nevolina; the Association of Russian Pharmaceutical Manufacturers, represented by General Director Viktor Dmitriev; the Association of International Pharmaceutical Manufacturers, represented by Executive Director Vladimir Shipkov; the Association “Rosmedprom”, represented by President Yuriy Kalinin; the International Medical Device Manufacturers Association, represented by Executive Director Sergey Kolosov; and National Immunobiological Company represented by General Director Mariam Khubieva.
Introducing company interests, on which share it is necessary about 80 % made and sold in the world of pharmaceutical production and the medical equipment, AIPM considers as the priority cooperation with the Russian bodies of public health services, and also with legislative and executive branches of the power, for the purpose of working out of the program of creation of favorable conditions for sale and-or production of the international pharmaceutical companies in territory of the Russian Federation